Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025)

Benitec Biopharma has reported Free Cash Flow over the past 7 years, most recently at -$3.7 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$3.7 million for Q4 2025, up 51.33% from a year ago — trailing twelve months through Dec 2025 was -$18.4 million (up 15.54% YoY), and the annual figure for FY2025 was -$23.6 million, down 20.55%.
  • Free Cash Flow reached -$3.7 million in Q4 2025 per BNTC's latest filing, down from -$3.4 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$2.0 million in Q1 2021 and bottomed at -$8.2 million in Q2 2025.
  • Median Free Cash Flow over the past 5 years was -$4.2 million (2021), compared with a mean of -$4.6 million.
  • The largest annual shift saw Free Cash Flow plummeted 160.6% in 2021 before it soared 51.33% in 2025.
  • Over 5 years, Free Cash Flow stood at -$3.3 million in 2021, then crashed by 76.25% to -$5.9 million in 2022, then rose by 9.48% to -$5.3 million in 2023, then tumbled by 45.34% to -$7.7 million in 2024, then skyrocketed by 51.33% to -$3.7 million in 2025.
  • Business Quant data shows Free Cash Flow for BNTC at -$3.7 million in Q4 2025, -$3.4 million in Q3 2025, and -$8.2 million in Q2 2025.